RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Lilly Eli & Co

A collection of news and information related to Lilly Eli & Co published by this site and its partners.

Top Lilly Eli & Co Articles see all

Displaying items 1-5
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the companies said.
  • Novartis to buy GlaxoSmithKline cancer unit for up to $16 billion

    Novartis to buy GlaxoSmithKline cancer unit for up to $16 billion
    Swiss pharmaceutical giant Novartis AG announced a series of multibillion-dollar deals Tuesday with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.  The...

    Takeda and Eli Lilly ordered to pay $9 billion over Actos drug

    Takeda and Eli Lilly ordered to pay $9 billion over Actos drug
    A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos. The jury in Lafayette,...

    Takeda, Eli Lilly must pay $9 billion in punitive damages over Actos

    Takeda, Eli Lilly must pay $9 billion in punitive damages over Actos
    Drugmakers Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a total of $9 billion in punitive damages after a Louisiana jury decided the companies did not disclose cancer risks of their diabetes medicine Actos. Japan-based Takeda said...

    Jury hits Takeda, Eli Lilly with $9-billion penalty

    Jury hits Takeda, Eli Lilly with $9-billion penalty
    TOKYO — A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co., to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The drug companies said Tuesday they will...